Close Menu
News JournosNews Journos
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
Editors Picks

Tesla Manufacturing Chief Omead Afshar Dismissed by Elon Musk

June 26, 2025

Trump Claims Iran Provided Advance Warning of Counterstrikes on U.S. Base in Qatar

June 23, 2025

U.S. Credit Rating Downgraded by Moody’s Amid Rising Government Debt

May 16, 2025

Sen. Cory Booker Delivers Extended Speech in Senate Protest Against Trump Policies

April 1, 2025

Trump Proposes Significant EPA Budget Cuts, Raising Concerns Among Workers and Environmentalists

February 26, 2025
Facebook X (Twitter) Instagram
Latest Headlines:
  • National Public Data Reappears Online Following Major Breach
  • Venezuela Again Sends Military Aircraft Over U.S. Navy Ship, Pentagon Reports
  • Maine Sees 3 Active TB Cases Amid Global Health Concerns
  • OpenAI Collaborates with Greek Secondary Education and Start-Ups for ‘Intelligence Age’ Preparation
  • Reactions Emerge Over EÄŸitim-İş Ex Officio Appointment and Non-Field Assignments
  • Six Magazine Staff Indicted Over Controversial Cartoon Depicting Muhammad and Moses
  • Roblox Unveils Short-Video and AI Features While Addressing Child Safety Concerns
  • 475 Detained in Major Hyundai Raid in Georgia by ICE and Other Agencies
  • RFK Jr. Claims Former CDC Director Misled on Vaccine Approval Pressure
  • Anthropic Settles Copyright Lawsuit with Authors for $1.5 Billion
  • Debbie Gibson Celebrates Career Milestones and Family Support: “I’m Thriving More Than Ever”
  • Salmonella Outbreak Associated with Meal Delivery Service Sickens Over a Dozen, Hospitalizes Seven
  • Venezuelan Aircraft Approaches US Navy Vessel in Provocative Maneuver
  • Retired Accountant Fulfills Lifetime Dream by Joining LSU Tiger Marching Band at 66
  • EU Imposes $3.45 Billion Antitrust Fine on Google
  • Midday Stock Movers: AVGO, NX, LULU on the Rise
  • Kenvue Shares Fall 10% Following Tylenol Autism Allegations
  • Home Wi-Fi Networks May Endanger Personal Data Security
  • Lisbon Funicular Derails, Claiming at Least 15 Lives
  • Trump Endorses Kennedy Following Intense Senate Hearing
Facebook X (Twitter) Instagram
News JournosNews Journos
Subscribe
Friday, September 5
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
News JournosNews Journos
You are here: News Journos » Business » Kenvue Shares Fall 10% Following Tylenol Autism Allegations
Kenvue Shares Fall 10% Following Tylenol Autism Allegations

Kenvue Shares Fall 10% Following Tylenol Autism Allegations

News EditorBy News EditorSeptember 5, 2025 Business 6 Mins Read

Shares of Kenvue Inc. experienced a significant drop of over 10% following reports that U.S. Health and Human Services Secretary Robert F. Kennedy Jr. may link the company’s popular pain reliever, Tylenol, to autism when used by pregnant women. The anticipated report is expected to be released this month and may also suggest a potential treatment for autism derived from folate. Amid the growing concerns, Kenvue has reiterated its stance on the safety of acetaminophen, the active ingredient in Tylenol, particularly during pregnancy.

Article Subheadings
1) The Controversial Report on Autism and Tylenol
2) Ongoing Research and Findings
3) Kenvue’s Response to Allegations
4) Regulatory and Medical Community Perspectives
5) Future Implications and Legal Landscape

The Controversial Report on Autism and Tylenol

The impending report from the Department of Health and Human Services (HHS) has stirred controversy and concern among stakeholders, especially considering its potential implications for Kenvue and its widely used product, Tylenol. This report is set to investigate possible links between acetaminophen use in pregnant women and an increase in autism spectrum disorders among children. Notably, the findings of this report could have far-reaching consequences, not only for Kenvue’s financial standing but also for the pharmaceutical industry as a whole.

The report is scheduled for release this month, a timeline indicated by various media outlets. If Secretary Kennedy’s assertions are substantiated, it could potentially lead to a reevaluation of Tylenol’s safety profile during pregnancy, raising questions about its long history as a go-to over-the-counter medication for pain relief.

Specifically, concerns revolve around the health of unborn children and whether exposure to acetaminophen might contribute to developmental disorders, including autism. This is significant considering the increasing rates of reported autism cases in the U.S.

Ongoing Research and Findings

In the quest to understand the factors contributing to rising autism rates, various studies have scrutinized the role of medications like acetaminophen. While some research suggests a potential association between the drug and autism, others maintain that there is no causal link. The scientific community remains divided, citing varying methodologies, sample sizes, and research designs in these studies.

As the HHS prepares to unveil its findings, it has been noted that these conclusions will rely on “gold-standard science.” This indicates a commitment to rigorous scientific inquiry, yet the notion itself has raised questions about the reliability of previous studies that suggested potential risks associated with acetaminophen consumption. Common discourse now centers on what precise evidence the upcoming report will present.

The HHS has proposed that aside from examining the safety of Tylenol, the report may also introduce alternative treatment options derived from folate, potentially revolutionizing the approach to autism treatment. The underlying question, however, remains whether such an association between Tylenol and autism can withstand scientific scrutiny.

Kenvue’s Response to Allegations

In light of growing scrutiny and speculation regarding the report’s findings, Kenvue has firmly defended its product, asserting a continuous evaluation of the scientific evidence surrounding its safety. The company maintains that there is no credible evidence to link the use of Tylenol during pregnancy with an increased risk of autism in children.

A Kenvue spokesperson has noted that major health organizations, including the Food and Drug Administration (FDA), endorse the safety of acetaminophen when used as directed. The company emphasized that the benefits of pain relief during pregnancy are essential and should not be overshadowed by fears that lack solid scientific backing.

Moreover, Kenvue has highlighted that many of the lawsuits claiming a link between Tylenol use and autism have been dismissed or ruled in the company’s favor. This further strengthens its position that the drug remains safe for use in general and during pregnancy.

Regulatory and Medical Community Perspectives

Regulatory bodies have maintained that appropriate use of acetaminophen during pregnancy does not pose significant risks to fetal development, aligning with Kenvue’s stance. The FDA asserts that, upon evaluation, it has not found “clear evidence” linking acetaminophen with adverse developmental outcomes.

The American College of Obstetricians and Gynecologists has echoed these sentiments, asserting that acetaminophen is safe for use—as long as it is administered following medical advice. This consensus among medical professionals indicates a cautious optimism regarding the drug’s safety, though the potential for ongoing implications from the forthcoming report looms large.

Healthcare providers often recommend acetaminophen for expectant mothers, stressing the importance of consultation before taking any medication. Such guidance aims to ensure that patients make informed decisions, particularly with regards to medication use in pregnancy.

Future Implications and Legal Landscape

The release of the HHS report holds significant potential to reshape the legal and regulatory environment surrounding Tylenol. Should the report conclude that a causal link exists, it could open the floodgates for further lawsuits against Kenvue and other manufacturers of acetaminophen-based products, vastly impacting the pharmaceutical industry.

Additionally, an association between Tylenol and autism could prompt a reevaluation of drug safety protocols and compel healthcare providers to reconsider medication recommendations for pregnant patients. Such a shift could fundamentally alter how medications are marketed and monitored to expectant mothers.

Given the high stakes involved, analysts have already indicated that proving such a causal link will be challenging. The resolution of prior lawsuits has often favored Kenvue, suggesting that the groundwork for legal battles may not be as straightforward as anticipated, which could serve to deter future legal actions.

No. Key Points
1 Kenvue shares declined over 10% following concerns over a potential link between Tylenol and autism.
2 The HHS report is expected to announce findings this month that could reshape public perception of acetaminophen.
3 Kenvue insists on the safety of Tylenol, supported by FDA and general medical community consensus.
4 Future legal implications abound should the report find a link between acetaminophen use and autism.
5 The upcoming HHS findings will likely influence regulatory discussions and public health guidelines.

Summary

The concern surrounding Kenvue’s Tylenol stems from an impending HHS report that may link its use during pregnancy to autism. As Kenvue reinforces its commitment to scientific safety, the report’s release could have profound implications not only for the company but for the wider pharmaceutical landscape and medical practices surrounding prenatal care.

Frequently Asked Questions

Question: What is the significance of the upcoming HHS report?

The HHS report will potentially examine the links between Tylenol usage during pregnancy and autism, which could reshape public perception and regulatory practices related to acetaminophen.

Question: How has Kenvue responded to the allegations?

Kenvue has rejected any claims linking Tylenol to autism, citing that both the FDA and leading medical organizations support the drug’s safety during pregnancy.

Question: What does the medical community say about acetaminophen use during pregnancy?

The medical community, including the American College of Obstetricians and Gynecologists, maintains that acetaminophen is safe to use during pregnancy when taken as directed and in consultation with healthcare providers.

allegations Autism Business Ethics Business Growth Business News Business Technology Consumer Trends Corporate Finance Corporate Strategy Economic Outlook Entrepreneurship fall Global Business Innovation Investment Opportunities Kenvue Leadership Management Market Trends Mergers & Acquisitions Retail Business shares Small Business Startups Supply Chain Tylenol
Share. Facebook Twitter Pinterest LinkedIn Email Reddit WhatsApp Copy Link Bluesky
News Editor
  • Website

As the News Editor at News Journos, I am dedicated to curating and delivering the latest and most impactful stories across business, finance, politics, technology, and global affairs. With a commitment to journalistic integrity, we provide breaking news, in-depth analysis, and expert insights to keep our readers informed in an ever-changing world. News Journos is your go-to independent news source, ensuring fast, accurate, and reliable reporting on the topics that matter most.

Keep Reading

Business

Micah Parsons Trade Analyzed Through Mathematical Insights

6 Mins Read
Business

Netflix Introduces Custom Clip Sharing Feature for Mobile Users

6 Mins Read
Business

Airplane Leasing Market Consolidates Following $7.4 Billion Acquisition of Air Lease

7 Mins Read
Business

Media Landscape Changes Drive Emergence of New Leadership

6 Mins Read
Business

Stock and Sales Decline Amid CEO Brian Cornell’s Termination

6 Mins Read
Business

Rolls-Royce Invests $75 Million to Expand South Carolina Manufacturing Facility

5 Mins Read
Journalism Under Siege
Editors Picks

Iran Warns U.S. Involvement in Israeli Strikes Could Trigger All-Out War

June 18, 2025

Trump Signs Order to Reduce Auto Tariffs Across Multiple Platforms

April 29, 2025

Trump Issues Full Pardon to Ex-Virginia Sheriff Convicted of Corruption

May 26, 2025

Report Reveals 383 Active DEI Programs at U.S. Colleges

April 18, 2025

Powell Requests Review of $2.5 Billion Renovation Amid Trump Criticism

July 14, 2025

Subscribe to News

Get the latest sports news from NewsSite about world, sports and politics.

Facebook X (Twitter) Pinterest Vimeo WhatsApp TikTok Instagram

News

  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Money Watch

Journos

  • Top Stories
  • Turkey Reports
  • Health
  • Tech
  • Sports
  • Entertainment

COMPANY

  • About Us
  • Get In Touch
  • Our Authors
  • Privacy Policy
  • Terms and Conditions
  • Accessibility

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

© 2025 The News Journos. Designed by The News Journos.

Type above and press Enter to search. Press Esc to cancel.

Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.
Go to mobile version